A retrospective review assessing perioperative safety of Tofacitinib in surgical Inflammatory Bowel Disease patients
Latest Information Update: 22 Dec 2020
At a glance
- Drugs Tofacitinib (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Adverse reactions
- 22 Dec 2020 New trial record
- 28 Oct 2020 Results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2020